From New Atlas:
“There is plenty of disagreement in the psychedelic community over how to end the drug war and achieve broader legalization.”
“Most psychedelic advocates picture a future where the drug war is over and people are free to responsibly use a number of currently illicit substances for healing, personal growth, or simple recreation. “
“But exactly how we get to that utopian future is the source of great acrimony and division in a once-unified alternative community that is increasingly moving towards the mainstream.”
Read more
Psychedelic drugs may reopen critical learning periods in the brain.
Recent research shows that in adult mice, psychedelic drugs including LSD, ketamine and psilocybin have been shown to reopen the brain to a critical window for social learning usually only seen in adolescents.
Read more
The psychedelic space has grown rapidly and quickly led to disagreements, attempts at profiting and patenting.
A recent psychedelic conference showed there is a widening rift in the community.
Read more
Compass Pathways published the long awaited results of its phase 2 clinical trial for the treatment of depression with psilocybin–assisted psychotherapy in the New England Journal of Medicine.
Psilocybin showed rapid antidepressant effects for most patients, but only 1 in 5 participants showed significant improvement at 12 weeks.
Read more
The harms of psychedelics need to be put Into context.
As psychedelic therapy trials get bigger and the drugs become more accessible, researchers need to start talking about their potential adverse effects.
Read more
Reports of the clinical effects of psychedelic therapy — loosening memories and habits that are deeply embedded — are stacking up.
Read more